Integrated PTSD and Chronic Pain Treatment
This study is testing a new approach to help people who experience both post-traumatic stress disorder (PTSD) and chronic pain. It uses a treatment called "Integrated Treatment for PTSD and Chronic Pain," which combines parts of two proven therapies: Prolonged Exposure (for PTSD) and Cognitive Behavioral Therapy for Chronic Pain. The treatment involves 12 virtual therapy sessions, each 90 minutes long, twice a week. Researchers want to see how many people are interested, how many join, and how many sessions they attend. You might be able to join if you are 18 or older, speak English, have both PTSD and chronic pain (pain severity of 4 or more out of 10 for at least 3 months), and are medically stable. This study is currently recruiting about 20 participants.
- Study design
- This study is an interventional study with a planned enrollment of 20 participants. It is not specified if it is randomized or blinded.
- What's involved
- You would participate in 12 virtual psychotherapy sessions, each 90 minutes long, scheduled twice per week. These sessions would last for approximately 6 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study measures session attendance at approximately 6 weeks, which is the post-treatment assessment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Integrated PTSD and Chronic Pain Treatment
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- JoAnn Difede, PhD · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility Indicator: Number of Participants ScreenedBaseline
Feasibility assessment will include number of participants screened defined as number of individuals who complete our initial eligibility screener.
- Feasibility Indicator: EnrollmentBaseline
Feasibility assessment will include enrollment defined as number of participants signing the informed consent form.
- Feasibility Indicator: Number of Sessions AttendedPost-Treatment Assessment at approximately 6 weeks
Feasibility assessment will include the number of sessions attended on average (out of 12).
- Feasibility Indicator: Attrition PercentagePost-Treatment Assessment at approximately 6 weeks
A feasibility measure of attrition will be assessed by examining the percent of individuals who did not complete all 12 intervention sessions.
- Feasibility Indicator: Number of Assessments AttendedBaseline and Post-Treatment Assessment at approximately 6 weeks
A feasibility indicator of number of assessments (baseline and post-treatment) attended will be measured.
- Feasibility Indicator: Percentage of Self-Reports CompletedBaseline, Post-Intervention at approximately 6 weeks, Every Other Treatment Session (Every 2 weeks up to 12 weeks)
Self-reports are administered at each assessment (baseline and post-intervention) as well as every other treatment session (every 2 weeks up to 12 weeks). Therefore, there are 8 total self-report assessments and the percentage of those completed will be calculated.
- Intervention SatisfactionPost-Treatment Assessment at approximately 6 weeks
Intervention satisfaction will be rated with a Likert scale ranging from 1-10 with greater scores indicating higher satisfaction.
- Intervention AcceptabilityPost-Treatment Assessment at approximately 6 weeks
Intervention acceptability will be measured on a Likert scale ranging from 1-10 with greater scores indicating higher acceptability.
- Qualitative Intervention FeedbackPost-Treatment Assessment at approximately 6 weeks
Open-ended questions that include assessing overall impressions of treatment, feedback on the frequency and length of sessions, challenges or barriers, likelihood of recommending this treatment to a friend, and comparison of this treatment to other treatments received in the past.